Articles on Clinical research

Displaying all articles

People with ALS gradually lose the ability to perform voluntary movements due to a loss of communication between the nervous system and the muscles. (Shutterstock)

A promising new study could lead to a reduction in symptoms of amyotrophic lateral sclerosis (ALS)

Mari Carmen Pelaez, Université Laval; Antoine Desmeules, Université Laval, and Chantelle F. Sephton, Université Laval

A new study shows that it is possible to reduce the symptoms of amyotrophic lateral sclerosis by reducing the inflammation caused by immune cells in the brain.
Over the years and to this day, many health professionals have supported the theory that flat feet pose a major risk factor for musculoskeletal disorders. (Shutterstock)

What if flat feet were…normal? Debunking a myth about injuries

Gabriel Moisan, Université du Québec à Trois-Rivières (UQTR)

Having asymptomatic flat feet is not a problem and does not require treatment. It’s important to debunk this common myth.
It takes around 17 years for medical research to translate into clinical practice. shapecharge/E+ via Getty Images

One way to speed up clinical trials: Skip right to the data with electronic medical records

Kevin Kip, University of Pittsburgh; Erin McCreary, University of Pittsburgh, and Oscar Marroquin, University of Pittsburgh

In health care crises, researchers can avoid waiting for clinical trial results by using data from health care systems to analyze the effectiveness of treatments for COVID-19 and other illnesses.
Creating a safe space for patients to ask questions and provide fully informed consent could help increase clinical trial recruitment. FatCamera/E+ via Getty Images

Yes, Black patients do want to help with medical research – here are ways to overcome the barriers that keep clinical trials from recruiting diverse populations

Julia Liu, Morehouse School of Medicine and RaKetra Snipes, Morehouse School of Medicine

Overcoming the access barriers and biases that underrepresented and underserved communities face could not only improve research participation but also improve care.
Do the benefits of approving a drug before confirming it works outweigh the potential costs? monkeybusinessimages/iStock via Getty Images Plus

The FDA’s big gamble on the new Alzheimer’s drug

C. Michael White, University of Connecticut

The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
Experts have called for a moratorium on clinical research with CRISPR/Cas9 gene editing. of the germline — that is changing heritable DNA in sperm, eggs or embryos to make genetically modified children. (Shutterstock)

CRISPR gene editing: Why we need Slow Science

Landon J Getz, Dalhousie University and Graham Dellaire, Dalhousie University

CRISPR gene editing should learn from the Slow Food movement. Scientists must allow time for critical conversations and perfecting of techniques before rewriting the source code of humanity.

Related Topics

  1. Biomedical research
  2. Clinical trials
  3. COVID-19
  4. Health disparities
  5. Health research
  6. Hemp products
  7. ligaments
  8. Muscles
  9. Musculoskeletal
  10. Research

Top contributors

More